Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study. - Wikidata - wikimedia - TriplyDB

Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.

Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.

http://www.wikidata.org/entity/Q35914597

about

Understanding and improving health education among first-time parents of infants with sickle cell anemia in Alabama: a mixed methods approach.Stroke in patients with sickle cell disease.Reticulocytosis and anemia are associated with an increased risk of death and stroke in the newborn cohort of the Cooperative Study of Sickle Cell Disease.Systematic review of interventional sickle cell trials registered in ClinicalTrials.gov.Interventions for preventing silent cerebral infarcts in people with sickle cell disease.Impact of hydroxyurea on clinical events in the BABY HUG trial.Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.Hydroxycarbamine: from an Old Drug Used in Malignant Hemopathies to a Current Standard in Sickle Cell Disease.Emerging drugs for sickle cell anemia.Hydroxyurea (hydroxycarbamide) for sickle cell disease.Interventions for chronic kidney disease in people with sickle cell disease.Sickle Cell Disease and Stroke: Diagnosis and Management.Prevalence of acute kidney injury during pediatric admissions for acute chest syndrome.Evaluating risk factors for chronic kidney disease in pediatric patients with sickle cell anemia.Autosplenectomy in severity of sickle cell diseases.Perception of pain among pediatric patients with sickle cell pain crisis.Graph Lasso-Based Test for Evaluating Functional Brain Connectivity in Sickle Cell Disease.Evaluation of a Portable Haemoglobin Metre Performance in Children with Sickle Cell Disease and Implications for Healthcare in Resource-poor Settings.Severe anemia early in life as a risk factor for sickle-cell kidney disease.Expected Sonographic Appearance of the Spleen in Children and Young Adults With Sickle Cell Disease: An Update.Low-dose hydroxycarbamide therapy may offer similar benefit as maximum tolerated dose for children and young adults with sickle cell disease in low-middle-income settings

P2860

Q27314693-1EBC1B1B-8C27-49F4-8829-58D3BF172F2A Q30650303-4702530D-8B3E-4C4E-99E1-31CC7E513645 Q34052855-2B4DC3BD-517C-4144-9CB4-A112654E5678 Q36276013-9D6E1093-09AB-49F3-B113-1A9EBFCA9EA7 Q36370980-D956164B-FF0C-45AB-BE22-A325D54CBB92 Q36425423-65355CB5-948A-4D26-9D02-D914690DCE73 Q37251490-788862A8-0FFF-4A17-B4F2-480C1AFC05D2 Q37677221-A6715573-1EF4-436C-8709-0DA3E3459379 Q38272226-0281F34E-C9D3-4645-A153-0FDFCE10AD06 Q38692796-E9127F05-2ECA-40F6-933E-F764DD7E2AD0 Q38696578-DA7A6570-045C-4215-902B-72AD0B01A6EC Q38732049-855648AC-A602-499C-9810-75F03B13BBAD Q38787386-9225C028-85E6-4B75-B03F-C470AAFA7F34 Q38851119-A5D8B0FD-A377-4FF5-8768-F72F70C59C15 Q40205269-014E0F87-94A1-4CDC-8362-2739DBD8262D Q43426236-7BE29707-B840-489D-A93C-9E00AE146359 Q43723150-26841D9D-28BF-4548-9A42-B1DD987D5412 Q46635240-8A70AEC0-372C-45AF-9A75-B83868E8B061 Q48179508-97B806EE-4E63-4238-9FD5-75A9C79709DB Q53077043-E3A8C822-D772-40ED-A0C1-9ACB9991D615 Q58765141-647EFDCE-4932-4B31-BB45-8A340A0A1DB2

P2860

Influence of severity of anemia on clinical findings in infants with sickle cell anemia: analyses from the BABY HUG study.

http://www.wikidata.org/entity/Q35914597

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Influence of severity of anemi ...... lyses from the BABY HUG study.

@ast

Influence of severity of anemi ...... lyses from the BABY HUG study.

@en

type

label

Influence of severity of anemi ...... lyses from the BABY HUG study.

@ast

Influence of severity of anemi ...... lyses from the BABY HUG study.

@en

prefLabel

Influence of severity of anemi ...... lyses from the BABY HUG study.

@ast

Influence of severity of anemi ...... lyses from the BABY HUG study.

@en

P1433

Q35914597-12F2D8B7-D239-4B03-99E6-B3D38F95CB82

P1476

Q35914597-371E905F-C834-4332-8AE8-E9CDFF2FEAC9

P2093

Q35914597-0F6B049B-8FF1-4465-A76D-80ED5458A0A7

Q35914597-178F04EE-B990-43C3-A9DC-5BCFE12A0657

Q35914597-3680917E-0D9A-4F1C-AC7E-967734E3B1B5

Q35914597-64D0E988-D514-4036-87D7-1D6406F45012

Q35914597-6841A5E9-D819-47E5-83A4-47801734A760

Q35914597-790C7E1E-0CD3-4FD5-A155-42F1909E15B3

Q35914597-8CA0D6B0-ACD6-4B6C-98AA-2168872BDFE2

Q35914597-9075D0D7-44A0-4F44-A5B9-79F49077F481

Q35914597-90ECA7A3-63E3-4F5C-AE67-BC7C07AB06D6

Q35914597-A0DC44F3-43F1-456E-B841-18513D871924

P2860

Q35914597-014C42E8-7446-48E2-8CFE-F498149F8508

Q35914597-0FC1F519-6B16-43AC-AC05-E033980838CB

Q35914597-29F8637E-0E9A-498F-9CEE-FFFD0395E1C1

Q35914597-559C65A3-36CD-4AF9-9952-33B88DF917A9

Q35914597-5C0C60B6-BE79-4E16-BF5F-7CFF24186CA8

Q35914597-6D43507B-1D0B-47A9-8AB8-1F453E15B0A8

Q35914597-7AE808F2-B131-4919-AEE3-5190B06025DB

Q35914597-A9BC96FB-0867-4006-865B-E3145E88AF77

Q35914597-ACCDBBAB-9F9F-4C9E-A6D0-AED1BFC63340

Q35914597-B5D70640-0C80-4867-BB8E-1D99980B40A8

P304

Q35914597-D3A41B9D-8D83-45E2-AACD-81FC5D44A368

P31

Q35914597-AE9938EA-D10A-4665-ADB4-1988DE7659D1

P356

Q35914597-C6953A68-B385-4DB4-87E8-BEBF2FA839CA

P433

Q35914597-BA79948E-EDB3-4F3E-B9AD-6188E99C694B

P478

Q35914597-4BF1F518-99D5-40EA-99C8-3E8C35F89C67

P577

Q35914597-E688C5E7-FA9F-4AF1-84AA-6D1AB166481C

P698

Q35914597-EB80A274-643F-4D14-9A47-0E12607E8E82

P921

Q35914597-C56D628D-7D9F-4714-97BD-640B8D0690AA

P932

Q35914597-1CA2224D-BFD8-47B9-A032-2E7AE9C5B091

P356

P1433

Pediatric Blood & Cancer

P1476

Influence of severity of anemi ...... lyses from the BABY HUG study.

@en

P2093

BABY HUG Investigators

http://www.w3.org/2001/XMLSchema#string

James F Casella

http://www.w3.org/2001/XMLSchema#string

Jeffrey D Lebensburger

http://www.w3.org/2001/XMLSchema#string

Ming Lu

http://www.w3.org/2001/XMLSchema#string

R Clark Brown

http://www.w3.org/2001/XMLSchema#string

Rathi V Iyer

http://www.w3.org/2001/XMLSchema#string

Scott T Miller

http://www.w3.org/2001/XMLSchema#string

Sharada Sarnaik

http://www.w3.org/2001/XMLSchema#string

Thomas H Howard

http://www.w3.org/2001/XMLSchema#string

Winfred C Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic hyper-hemolysis in sickle cell anemia: association of vascular complications and mortality with less frequent vasoocclusive pain

The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up.

Stroke in a cohort of patients with homozygous sickle cell disease.

Hydroxyurea therapy requires HbF induction for clinical benefit in a sickle cell mouse model.

Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.

Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions

Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort.

NIH consensus development statement on hydroxyurea treatment for sickle cell disease.

P304

675-678

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PBC.24037

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

59

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22190441

http://www.w3.org/2001/XMLSchema#string

P921

sickle-cell disease

P932

3337342

http://www.w3.org/2001/XMLSchema#string